Hollings Renton - Net Worth and Insider Trading
Hollings Renton Net Worth
The estimated net worth of Hollings Renton is at least $818,194 dollars as of 2024-12-28. Hollings Renton is the Director of Cepheid and owns about 9,517 shares of Cepheid (CPHD) stock worth over $503,925. Hollings Renton is the Director of Portola Pharmaceuticals Inc and owns about 16,020 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $288,841. Hollings Renton is also the Director of AnaptysBio Inc and owns about 1,950 shares of AnaptysBio Inc (ANAB) stock worth over $25,428. Details can be seen in Hollings Renton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hollings Renton has not made any transactions after 2024-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hollings Renton
Hollings Renton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hollings Renton owns 6 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Zymeworks Inc (ZYME) , and AnaptysBio Inc (ANAB) among others .
Click here to see the complete history of Hollings Renton’s form 4 insider trades.
Insider Ownership Summary of Hollings Renton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTLA | Portola Pharmaceuticals Inc | 2020-07-02 | director |
| ZYME | Zymeworks Inc | 2022-12-21 | director |
| ANAB | AnaptysBio Inc | 2024-11-29 | director |
 | | 2016-11-04 | director |
| | 2004-01-12 | director |
| | 2012-06-13 | director |
Hollings Renton Latest Holdings Summary
Hollings Renton currently owns a total of 3 stocks. Among these stocks, Hollings Renton owns 9,517 shares of Cepheid (CPHD) as of November 7, 2014, with a value of $503,925 and a weighting of 61.59%. Hollings Renton owns 16,020 shares of Portola Pharmaceuticals Inc (PTLA) as of November 1, 2019, with a value of $288,841 and a weighting of 35.3%. Hollings Renton also owns 1,950 shares of AnaptysBio Inc (ANAB) as of November 29, 2024, with a value of $25,428 and a weighting of 3.11%.
Latest Holdings of Hollings Renton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPHD | Cepheid | 2014-11-07 | 9,517 | 52.95 | 503,925 |
| PTLA | Portola Pharmaceuticals Inc | 2019-11-01 | 16,020 | 18.03 | 288,841 |
| ANAB | AnaptysBio Inc | 2024-11-29 | 1,950 | 13.04 | 25,428 |
Holding Weightings of Hollings Renton
Hollings Renton Form 4 Trading Tracker
According to the SEC Form 4 filings, Hollings Renton has made a total of 0 transactions in Cepheid (CPHD) over the past 5 years. The most-recent trade in Cepheid is the sale of 9,375 shares on November 7, 2014, which brought Hollings Renton around $478,781.
According to the SEC Form 4 filings, Hollings Renton has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 5,000 shares on November 1, 2019, which brought Hollings Renton around $150,000.
According to the SEC Form 4 filings, Hollings Renton has made a total of 3 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in AnaptysBio Inc is the sale of 10,000 shares on November 29, 2024, which brought Hollings Renton around $250,000.
Insider Trading History of Hollings Renton
- 1
Hollings Renton Trading Performance
Hollings Renton Ownership Network
Hollings Renton Owned Company Details
What does Portola Pharmaceuticals Inc do?
Who are the key executives at Portola Pharmaceuticals Inc?
Hollings Renton is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .
Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Portola Pharmaceuticals Inc Insider Transactions
Hollings Renton Mailing Address
Above is the net worth, insider trading, and ownership report for Hollings Renton. Currently GuruFocus does not have mailing address information for Hollings Renton.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
